Baxter International (NYSE:BAX) is restructuring its business, including a spin-off of its kidney care unit. The company is realigning its portfolio to concentrate on higher margin medical products.

Innovative system measures stomach motility to help clinicians identify enteral feeding intolerance Technology designed to help address malnutrition in the ICU and support clinical decision-making ...

Add Yahoo as a preferred source to see more of our stories on Google. The partnership aims to unify bedside technologies MUSC Health and Baxter have entered a multi-year partnership to advance the use ...

PHILADELPHIA, PA, UNITED STATES, March 5, 2026 /EINPresswire.com/ -- Bainbridge Health today announced that Baxter ...

Baxter International (NYSE:BAX) reported another substantial net loss for the recent quarter and full year. The company also recorded additional goodwill impairment charges tied to parts of its ...

Baxter International gets its buy rating from December reaffirmed, agreeing with today's bullish consensus from SA analysts and Wall Street. Positive drivers of the bull call include recent Q4 ...

Robert Kraal announced today on LinkedIn that he is departing Zimmer Biomet to lead the Baxter Connected Care business.

The Deerfield, Illinois-based company reported sales of $3.85 billion, in line with consensus. Baxter’s worldwide sales include continuing sales of $2.69 billion and discontinued operations (kidney ...

On Thursday, Baxter International Inc. (NYSE:BAX) reported a first-quarter 2025 adjusted EPS of 62 cents, beating the management guidance of 47 to 50 cents and the Wall Street estimate of 48 cents.

DUBLIN--(BUSINESS WIRE)--Oneview Healthcare, a leading provider of patient experience solutions is pleased to announce the extension of its strategic relationship with Baxter International Inc. for an ...

What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the healthcare industry showing significant job ...

INVESTORS WEREN'T HAPPY ABOUT SALES OF HUMIRA'S HEIRS-APPARENT: AbbVie stock plunged this morning after the drugmaker reported disappointing sales of new drugs that are supposed to offset declines in ...